Guicheney P, Baudouin-Legros M, Meyer P
Life Sci. 1987 Feb 16;40(7):615-21. doi: 10.1016/0024-3205(87)90261-x.
Beta-thromboglobulin (BTG) and platelet factor 4 (PF4), platelet alpha-granule specific proteins, and serotonin (5-HT) which is stored in dense granules are released when platelets are activated. To investigate in vivo platelet activation in uncomplicated essential hypertension, platelet 5-HT and PF4 contents, plasma BTG and PF4 concentrations, as well as urinary BTG levels were assessed in normotensive and hypertensive subjects. Plasma BTG and PF4 concentrations and urinary BTG levels were comparable in both groups. Mean platelet 5-HT content was significantly decreased in hypertensive subjects without modification of the intraplatelet PF4 content. These data suggest first of all that the decrease in platelet 5-HT content is due mainly to the inhibition of platelet 5-HT uptake previously described, and second of all that no significant in vivo platelet activation occurs in essential hypertensive subjects devoid of cardiovascular complications.
β-血小板球蛋白(BTG)和血小板第4因子(PF4)是血小板α-颗粒特异性蛋白,当血小板被激活时,储存于致密颗粒中的5-羟色胺(5-HT)会被释放出来。为了研究单纯原发性高血压患者体内的血小板激活情况,我们对血压正常者和高血压患者的血小板5-HT和PF4含量、血浆BTG和PF4浓度以及尿BTG水平进行了评估。两组患者的血浆BTG和PF4浓度以及尿BTG水平相当。高血压患者的平均血小板5-HT含量显著降低,而血小板内PF4含量未发生改变。这些数据首先表明,血小板5-HT含量的降低主要是由于先前所述的血小板5-HT摄取受到抑制,其次表明,在无心血管并发症的原发性高血压患者中,未发生显著的体内血小板激活。